To assess whether combinatorial treatment will synergistically block tumor formation, the orthotopically implanted tumors were allowed to grow for a week and mice were randomized into four drug treatment groups: control, trametinib, CENPE inhibitor, and trametinib plus CENPE inhibitor. The gene discussed is CENPE; the disease is neoplasm.